Feeds:
Posts
Comments

Posts Tagged ‘cell bank’

New Scaffold-Free 3D Bioprinting Method Available to Researchers

Posted in 3D Printing for Medical Application, Tissue Engineering, tagged , , , , , , , , on February 5, 2016| Leave a Comment »

New Scaffold-Free 3D Bioprinting Method Available to Researchers

Reporter: Irina Robu, PhD

 

UPDATED ON 2/6/2016

Kenzan

SOURCE

Bio 3D Printer Regenova with Kenzan method

http://https://www.3dprintingbusiness.directory/news/kenzan-method-3d-bioprinting-cyfuses-regenova-system/

SOURCE

Cyfuse and Cyberdyne Are Pushing the Boundaries of 3D Printed Human Engineering With Regenova

by TE Halterman | Mar 3, 2015 | 3D Printers, 3D Printing, Health 3D Printing |

http://3dprint.com/48312/cyfuse-and-cyberdyne-3d-printed-human-engineering/

 

Scafold-free

SOURCE

PUBLIC RELEASE: 3-FEB-2016

New scaffold-free 3-D bioprinting method available for first time in North America

Cell Applications primary cells and Regenova 3D Bio Printer from Cyfuse Biomedical combine to print robust 3-D tissue without introduction of extraneous scaffolding material

 

VIEW VIDEO

Regenova, Bio 3D Printer by Cyfuse

Cyfuse Biomedical

 

Cyfuse Biomedical K.K. and Cell Applications.Inc. publicized on February 3, 2016 that advanced tissue engineering services using 3D bioprinting approach will be available in North America. The services involved using Cyfuse Biomedica’s Regenova 3D Bio Printer, a state of the art robotic system that produces 3D tissues from cell and Cell Applications has created a pay by service bio-printing model that produces scaffold-free tissue available immediately to scientists in the U.S. and Canada for research use.

According to James Yu, Founder and CEO of Cell Applications having the Regenova 3D Bio Printer at our San Diego headquarters offers researchers an end-to-end, customized solution for creating scaffold-free, 3D-engineered tissues that diminish costs by reducing the lengthy processes typical in pharmaceutical drug discovery. In addition , Koji Kuchiishi, CEO of Cyfuse Biomedical having the Regenova 3D Bio Printer, combined with Cell Applications’ comprehensive, high-quality primary cell bank, offers researchers streamlined access to a nearly limitless selection of three dimensional tissues including those mimicking blood vessels, human neural tissue and liver constructs.

Unlike the other bioprinters on the market the bio-printer made by Regenova does not depend on scaffolding made of biomaterials such as collage or hydrogel to construct 3D tissue, the instrument assembles three dimensional microscopic tissue by forming spheroids, one at the time and lancing them on a fine needle array. The spheroids are guided by pre-programmed software which can be design and constructed into rods, spheres, tubes, sheets and other tissue configurations. In order for the engineered tissue to mature a bioreactor chamber is used. As the cells mature, they self-organize promoting strong, reliable tissue that can be further optimized by design of bio printer’s needle array that allows for optimum circulation of culture medium.

Source
http://www.cyfusebio.com/en/

Read Full Post »